NCT00335647View on ClinicalTrials.gov

Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2008

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

fluphenazine hydrochloride

Trial Locations (3)

11040

Long Island Jewish Medical Center, New Hyde Park

07601

Hackensack University Medical Center Cancer Center, Hackensack

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Sponsors

Lead Sponsor

Immune Control
All Listed Sponsors
lead

Immune Control

INDUSTRY